Randomized Phase II Trial of Either Fluorouracil, Parenteral Hydroxyurea, Interferon-??t-2a, and Filgrastim or Doxorubicin/Docetaxel in Patients with Advanced Gastric Cancer with Quality-of-Life Assessment
The Cancer Journal（2002）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要